Our Research

KCCIRC

The Frontier of Precision Oncology.

Moving beyond traditional discovery. We fuse ultra-high-resolution multi-omics, Agentic AI, and systems biology to anticipate, intercept, and cure complex malignancies.

Traditional oncological research has long relied on generalized models and trial-and-error methodologies. At KCCIRC, we have fundamentally shifted this paradigm. We treat cancer not as a static illness, but as a highly dynamic, multidimensional ecosystem.

By integrating spatial profiling, generative AI drug design, and high-performance computing, our decentralized research initiatives map the evolutionary trajectories of tumors at the single-cell and atomic levels. 

Our Research

The Kwatra Computational Cancer Institute & Research Center (KCCIRC) is internationally renowned for pioneering the convergence of artificial intelligence, multi-omics, and quantitative biology. Click a topic below to find out more about our work in each field. Our highly interdisciplinary research is focused into 15 key Research Themes that span the computational oncology spectrum.

Go to

  • AI-Driven Drug Discovery
  • Blood Tumours
  • Chromatin Biology & Epigenomics
  • Computational Immunology
  • Digital Pathology & Spatial AI
  • Digital Twins & Disease Forecasting
  • In-Silico Clinical Trials
  • Liquid Biopsy & Biomarker Discovery
  • Population Genomics
  • Radiomics & Medical Physics
  • Single-Cell Systems Biology
  • Solid Cancers
  • Structural Oncology
  • Tumor Microenvironment (TME) Modeling

AI-Driven Drug Discovery

We utilize Generative Diffusion Models and deep learning to explore ultra-high-dimensional chemical space, designing entirely novel small molecule inhibitors and programmable RNA therapeutics de novo for historically intractable driver mutations.

Blood Tumours

We computationally model the multi-omic and molecular basis of hematological malignancies, employing synthetic biology to design custom regulatory circuits and precision-engineered cellular therapies that maximize efficacy while neutralizing systemic toxicity.

Chromatin Biology & Epigenomics

Our teams investigate the dynamic regulatory grammar of the genome, decoding how DNA methylation, histone modifications, and 3D chromatin architecture control cellular destiny, trigger metastasis, and drive therapeutic resistance.

Clinical NLP & Knowledge Graphs

We engineer dynamic, AI-readable knowledge graphs and utilize specialized Oncology Large Language Models (LLMs) to automatically extract complex phenotypes from unstructured electronic health records, seamlessly linking global trial outcomes to multi-omic mutations.

Computational Immunology

We decode the immunological interactome using deep learning to design next-generation immunotherapies. Our focus includes the structural prediction of patient-specific neoantigen
binding for personalized cancer vaccines and reversing T-cell exhaustion.

Digital Pathology & Spatial AI

We are transforming diagnostic microscopy into quantitative, high-dimensional data science. By engineering spatial AI pipelines, we perform topological data analysis on Whole Slide Images (WSIs) to spatially resolve immune-excluded tumor margins and predict molecular subtypes.

Digital Twins & Disease Forecasting

We engineer high-fidelity, continuously updating in-silico replicas of patients. By running thousands of stochastic simulations on these mathematical models, we deterministically forecast disease trajectories and predict multidrug resistance timelines before clinical relapse.

In-Silico Clinical Trials

We aim to revolutionize the evidence generation paradigm by pioneering Synthetic Control Arms (SCA). By applying causal inference frameworks to vast repositories of Real-World Data (RWD), we dramatically accelerate regulatory trial timelines for rare and complex malignancies.

Liquid Biopsy & Biomarker Discovery

We develop extreme-sensitivity algorithms to deconvolute sparse molecular signals from physiological background noise. By integrating cfDNA mutational profiling with fragmentomics, we enable the real-time, non-invasive mapping of clonal dynamics and Minimal Residual Disease (MRD).

Population Genomics

We deploy cloud-native, planetary-scale High-Performance Computing (HPC) architectures to execute massive Genome-Wide Association Studies (GWAS). We aim to map the complex interplay between genetic susceptibility, the environmental exposome, and global cancer clusters.

Radiomics & Medical Physics

We look beyond human visual perception, extracting high-dimensional spatiotemporal biomarkers from standard medical scans. These “virtual biopsies” allow us to sculpt adaptive radiotherapy, aggressively targeting hypoxic tumor cores while rigorously sparing healthy tissue.

Single-Cell Systems Biology

We dissect cancer at the ultimate resolution of the individual cell. Integrating single-cell DNA, RNA, and spatial transcriptomics, we construct evolutionary trajectories to isolate and target
the highly resilient “persister cells” responsible for metastasis and relapse.

Solid Cancers

We build highly detailed mathematical and multi-omic models of the solid tumor microenvironment. Our algorithms map the intricate biochemical cross-talk, identifying precise nutrient dependencies, physical immune barriers, and hypoxia-driven resistance mechanisms across solid malignancies.

Structural Oncology

We chart the biophysical interactome at the atomic level. Utilizing state-of-the-art foundation models and molecular dynamics simulations, we uncover cryptic vulnerabilities in master oncogenic regulators and map novel allosteric networks on “undruggable” targets.

Tumor Microenvironment (TME) Modeling

We leverage spatial transcriptomics and systems biology to decode the multidimensional cellular ecosystems within the TME. Our goal is to algorithmically identify pathways that reverse local immunosuppression and halt the complex mechanical processes driving cancer spread.